Skip to main content

Neuropathic Anticonvulsant Medications

  • Chapter
Pain Management and Palliative Care

Abstract

Neuropathic pain medications have dramatically changed the armamentarium of treatment options available to pain medicine practitioners. It is important to be familiar with the indications, dosing, and side effects associated with each of these medications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AEDs:

Anti-epileptic drugs

AMPA:

2-(Aminomethyl)phenylacetic acid

AV:

Atrioventricular block

CBC:

Complete blood count

GABA:

Gamma-aminobutyric acid

HIV:

Human immunodeficiency virus

HTN:

Hypertension

IV:

Intravenous

LV:

Liver

MAOI:

Monamine oxidase inhibitor

NMDA:

N-Methyl-d-aspartate

PO BID:

Per os bis in die (Latin), twice a day

PO TID:

Per os ter in die (Latin), three times a day

TCAs:

Tricyclic antidepressant/s

References

  1. Schestatsky P, Nascimento OJ. What do general neurologists needs to know about neuropathic pain? Arq Neuropsiquiatr. 2009;67(3A):741–9.

    Article  PubMed  Google Scholar 

  2. Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12(4):304–14.

    Article  CAS  PubMed  Google Scholar 

  3. Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46(4):31–7.

    Article  CAS  PubMed  Google Scholar 

  4. LaRoche S. A new look at the second-generation antiepileptic drugs: a decade of experience. Neurologist. 2007;13(3):133–9.

    Article  PubMed  Google Scholar 

  5. Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics, interactions. Pharmacol Rep. 2009;61(2):197–216.

    Article  CAS  PubMed  Google Scholar 

  6. Gallop K. Review article: phenytoin use and efficacy in the ED. Emerg Med Australas. 2010;22(2):108–18.

    Article  PubMed  Google Scholar 

  7. Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB. PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012;22(6):466–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61(3):246–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Aronson JK, Hardman M, Reynolds DJ. ABC of monitoring drug therapy. Phenytoin. Br Med J. 1992;305(6863):1215–8.

    Article  CAS  Google Scholar 

  10. Von Winckelmann SL, Spriet I, Williams L. Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy. 2008;28(11):1391–400.

    Article  Google Scholar 

  11. Scheinfeld N. Phenytoin in cutaneous medicine: its uses, mechanisms, and side effects. Dermatol Online J. 2003;9(3):6.

    PubMed  Google Scholar 

  12. Craig S. Phenytoin poisoning. Neurocrit Care. 2005;3(2):161–70.

    Article  CAS  PubMed  Google Scholar 

  13. Al-Rubeaan K, Ryan EA. Phenytoin induced insulin insensitivity. Diabet Med. 2009;8(10):968–70.

    Article  Google Scholar 

  14. Backonja MM. Use of anticonvulsants for treatments of neuropathic pain. Neurology. 2002;59(5):S14–7.

    Article  PubMed  Google Scholar 

  15. Schachter SC. Pharmacology of antiepileptic drugs; 2012. www.uptodate.com. Retrieved 10 Dec 2012.

  16. Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2000;60(5):1029–52.

    Article  CAS  PubMed  Google Scholar 

  17. Krasowski MD. Therapeutic monitoring of the newer anti-epilepsy medication. Pharmaceuticals. 2010;3(6):1909–35.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Johannessen SI, Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet. 2006;45(11):1061–75.

    Article  CAS  PubMed  Google Scholar 

  19. Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118(2):69–86.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leena Mathew M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mathew, L., Kilcoyne, L. (2015). Neuropathic Anticonvulsant Medications. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2462-2_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2461-5

  • Online ISBN: 978-1-4939-2462-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics